XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Equity and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Stock-based Compensation Expense

Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Cost of revenue

 

$

131

 

 

$

130

 

 

$

421

 

 

$

467

 

Selling and marketing

 

 

399

 

 

 

564

 

 

 

1,261

 

 

 

1,464

 

Research and development

 

 

298

 

 

 

326

 

 

 

795

 

 

 

1,006

 

General and administrative

 

 

668

 

 

 

605

 

 

 

970

 

 

 

5,617

 

Total stock-based compensation

 

$

1,496

 

 

$

1,625

 

 

$

3,447

 

 

$

8,554

 

Stock Activity and Total Number of Shares Available for Grant

The following table presents the stock activity and the total number of shares available for grant as of September 30, 2024:

 

 

 

(in thousands)

 

Balance at December 31, 2023

 

 

1,059

 

Options Cancelled

 

 

6

 

Restricted Stock Granted

 

 

(214

)

Restricted Stock Forfeited

 

 

32

 

Performance Shares Granted

 

 

(171

)

Balance at September 30, 2024

 

 

712

 

Stock Option Activity

 

 

Options Outstanding

 

 

 

Number of
Shares
Underlying
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding at December 31, 2023

 

 

1,041,452

 

 

$

9.10

 

 

 

4.22

 

 

$

3,137,285

 

Options Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Options Exercised

 

 

(355,344

)

 

 

8.25

 

 

 

 

 

 

 

Options Forfeited

 

 

(5,846

)

 

 

30.86

 

 

 

 

 

 

 

Outstanding at September 30, 2024

 

 

680,262

 

 

$

9.36

 

 

 

4.64

 

 

$

4,617,323

 

Vested and expected to vest at September 30, 2024

 

 

680,248

 

 

$

9.43

 

 

 

4.64

 

 

$

4,617,323

 

Exercisable at September 30, 2024

 

 

679,389

 

 

$

9.42

 

 

 

4.64

 

 

$

4,617,323

 

Restricted Stock Awards  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Restricted Stock Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Nonvested restricted stock at December 31, 2023

 

 

764,942

 

 

$

14.76

 

Granted

 

 

213,673

 

 

 

17.02

 

Vested

 

 

(323,571

)

 

 

14.23

 

Shares forfeited

 

 

(31,961

)

 

 

13.08

 

Nonvested restricted stock at September 30, 2024

 

 

623,083

 

 

$

15.89